van Dyck_2000_Arch.Gen.Psychiatry_57_157

Reference

Title : Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group - van Dyck_2000_Arch.Gen.Psychiatry_57_157
Author(s) : van Dyck CH , Newhouse PA , Falk WE , Mattes JA
Ref : Arch Gen Psychiatry , 57 :157 , 2000
Abstract : van Dyck_2000_Arch.Gen.Psychiatry_57_157
ESTHER : van Dyck_2000_Arch.Gen.Psychiatry_57_157
PubMedSearch : van Dyck_2000_Arch.Gen.Psychiatry_57_157
PubMedID: 10665618

Related information

Citations formats

van Dyck CH, Newhouse PA, Falk WE, Mattes JA (2000)
Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group
Arch Gen Psychiatry 57 :157

van Dyck CH, Newhouse PA, Falk WE, Mattes JA (2000)
Arch Gen Psychiatry 57 :157